# Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-2-trial-of-selective-tyrosine-kinase-2-inhibition-in-psoriasis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kim Papp,Kenneth B. Gordon,Diamant Thaçi,Akimichi Morita,Melinda Gooderham,Peter Foley,Ihab Girgis,Sudeep Kundu,Subhashis Banerjee |
| Citations | 420 |
| DOI | 10.1056/nejmoa1806382 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1806382?articleTools=true |
| OpenAlex ID | https://openalex.org/W2892136519 |
| PMID | 30205746 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Melinda Gooderham](https://scholariq.org/researchers/melinda-gooderham/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.